LBX2 and central nervous system cancer: The results suggested that LBX2-AS1 was 4-fold and 10-fold highly expressed in glioma tissues from TCGA-LGG and TCGA-GBM compared with normal brains from GTEx, expression of LBX2-AS1 was nearly 3-fold higher in high-grade glioma (GBM) compared with low-grade glioma (LGG) (Fig. 1a).